Related references
Note: Only part of the references are listed.Systemic hormonal contraception and risk of venous thromboembolism
Oskari Heikinheimo et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)
Estradiol Valerate Vs. Ethinylestradiol In Combined Oral Contraceptives: Effects On The Pituitary-Ovarian Axis
Annina Haverinen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Ethinyl estradiol vs estradiol valerate in combined oral contraceptives - Effect on glucose tolerance: A randomized, controlled clinical trial
Annina Haverinen et al.
CONTRACEPTION (2021)
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism
Suzanne Reed et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2021)
Estradiol Valerate in COC Has More Favorable Inflammatory Profile Than Synthetic Ethinyl Estradiol: A Randomized Trial
Marika H. Kangasniemi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study
Marcus Ljungkvist et al.
HAEMOPHILIA (2019)
Standardization and evaluation of the performance of the thrombin generation test under hypo- and hypercoagulability conditions
Rita Carolina Figueiredo Duarte et al.
HEMATOLOGY TRANSFUSION AND CELL THERAPY (2019)
Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
Sara Calzavarini et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Normal pregnancy is associated with an increase in thrombin generation from the very early stages of the first trimester
C. N. Bagot et al.
THROMBOSIS RESEARCH (2017)
Endogenous thrombin potential changes during the first cycle of oral contraceptive use
Carolyn L. Westhoff et al.
CONTRACEPTION (2017)
Impact of estrogen type on cardiovascular safety of combined oral contraceptives
Juergen Dinger et al.
CONTRACEPTION (2016)
The epidemiology of venous thromboembolism
John A. Heit et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
Alain Weill et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
Alain Weill et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment
Frank Z. Stanczyk et al.
CONTRACEPTION (2013)
Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial
M. Raps et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive
Christine Klipping et al.
Drugs in research & development (2013)
Progestin-only contraception and venous thromboembolism
M. A. Blanco-Molina et al.
THROMBOSIS RESEARCH (2012)
Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive
Wolfgang Junge et al.
CLINICAL DRUG INVESTIGATION (2011)
Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism
Ulla M. Agren et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2011)
Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years
Kristina Sonnevi et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol
Pascale Gaussem et al.
THROMBOSIS AND HAEMOSTASIS (2011)
The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy
C. N. Bagot et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Mechanisms of Estrogen-Induced Venous Thromboembolism
Svetlana N. Tchaikovski et al.
THROMBOSIS RESEARCH (2010)
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
H. A. A. M. VAN VLIET et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters
Inka Wiegratz et al.
CONTRACEPTION (2008)
Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography
Svetlana N. Tchaikovski et al.
THROMBOSIS AND HAEMOSTASIS (2007)
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations
Elisabeth R. Pomp et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence
A. van Hylckama Vlieg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study
J Jespersen et al.
CONTRACEPTION (2003)
The Calibrated Automated Thrombogram (CAT):: A universal routine test for hyper- and hypocoagulability
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2002)
Share Paper
